CB

Constructive Bio at TIDES Europe 2026

Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website

Constructive Bio takes part in 2 sessions at TIDES Europe 2026 in Amsterdam. Its sessions focus on obesity therapeutics, including the European path from lab to launch alongside Novo Nordisk, Aphaia Pharma and Cantoni Therapeutics. The most specific topic is engineering GLP-1 peptides through targeted, site-specific modifications.

OrganizationTIDES Europe 2026 Attendance
CB
Constructive Bio
Cambridge, United Kingdom
Biotech
Develops genetic code expansion technology to make proteins and peptides containing non-standard amino acids.
Talk
Fri Nov 6
09:10–10:00
Keynote Panel: From Lab to Launch - Navigating the European Obesity Therapeutics Landscape
What it takes to turn obesity research into a product Europe will approve, manufacture at scale and actually pay for.
Post-event symposium · with Cantoni Therapeutics, Novo Nordisk, Aphaia Pharma
Talk
Fri Nov 6
13:30–13:45
Presentation: Engineering Advanced GLP-1 Peptides Through Targeted Site-Specific Modifications
Post-event symposium: Technology and Process Innovation Spotlight

Explore the full TIDES Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full TIDES Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Constructive Bio

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Informa Connect or TIDES Europe. Submit a correction